EC Number | Crystallization (Comment) | Organism |
---|---|---|
3.2.1.114 | - |
Drosophila melanogaster |
3.2.1.114 | in complex with inhibitors (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one and (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one, to 1.08 A and 1.74 A resolution, respectively | Drosophila melanogaster |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.2.1.24 | (1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol | - |
Canavalia sp. | |
3.2.1.24 | (1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol | - |
Homo sapiens | |
3.2.1.24 | (2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | - |
Canavalia sp. | |
3.2.1.24 | (2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | - |
Homo sapiens | |
3.2.1.24 | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | - |
Canavalia sp. | |
3.2.1.24 | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | - |
Homo sapiens | |
3.2.1.24 | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | - |
Canavalia sp. | |
3.2.1.24 | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | - |
Homo sapiens | |
3.2.1.114 | (1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol | - |
Drosophila melanogaster | |
3.2.1.114 | (2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | - |
Drosophila melanogaster | |
3.2.1.114 | (2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | - |
Canavalia ensiformis | |
3.2.1.114 | (2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | - |
Drosophila melanogaster | |
3.2.1.114 | (2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | - |
Homo sapiens | |
3.2.1.114 | (2S,3R,4S)-2-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]pyrrolidine-3,4-diol | - |
Homo sapiens | |
3.2.1.114 | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | - |
Drosophila melanogaster | |
3.2.1.114 | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | - |
Drosophila melanogaster | |
3.2.1.114 | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | competitive inhibitor | Canavalia ensiformis | |
3.2.1.114 | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | competitive inhibitor | Drosophila melanogaster | |
3.2.1.114 | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | - |
Homo sapiens | |
3.2.1.114 | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | competitve inhibitor | Canavalia ensiformis | |
3.2.1.114 | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | competitve inhibitor | Drosophila melanogaster | |
3.2.1.114 | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | competitve inhibitor | Homo sapiens | |
3.2.1.114 | (3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxy-1-methylpyrrolidin-2-one | - |
Homo sapiens | |
3.2.1.114 | (3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxypyrrolidin-2-one | - |
Homo sapiens | |
3.2.1.114 | mannostatin | - |
Homo sapiens | |
3.2.1.114 | swainsonine | competitve inhibitor | Canavalia ensiformis | |
3.2.1.114 | swainsonine | competitve inhibitor | Drosophila melanogaster | |
3.2.1.114 | swainsonine | competitve inhibitor | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.2.1.24 | 0.55 | - |
4-methylumbelliferyl-alpha-D-mannopyranoside | pH 5.0, 37°C, HCEC cell layer | Homo sapiens | |
3.2.1.24 | 0.65 | - |
4-methylumbelliferyl-alpha-D-mannopyranoside | pH 5.0, 37°C, LNZ-308 cell layer | Homo sapiens | |
3.2.1.24 | 1.065 | - |
4-methylumbelliferyl-alpha-D-mannopyranoside | pH 5.0, 37°C, LN-18 cell layer | Homo sapiens | |
3.2.1.114 | 0.55 | - |
4-methylumbelliferyl-alpha-D-mannopyranoside | extracted from endothelial cells HCEC | Homo sapiens | |
3.2.1.114 | 0.65 | - |
4-methylumbelliferyl-alpha-D-mannopyranoside | extracted from human glioblastoma cells LNZ308 | Homo sapiens | |
3.2.1.114 | 1.065 | - |
4-methylumbelliferyl-alpha-D-mannopyranoside | extracted from human glioblastoma cells LN18 | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.2.1.114 | Golgi apparatus | - |
Drosophila melanogaster | 5794 | - |
3.2.1.114 | Golgi apparatus | - |
Homo sapiens | 5794 | - |
3.2.1.114 | Golgi apparatus | - |
Canavalia ensiformis | 5794 | - |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.2.1.24 | Canavalia sp. | - |
- |
- |
3.2.1.24 | Homo sapiens | - |
- |
- |
3.2.1.114 | Canavalia ensiformis | - |
- |
- |
3.2.1.114 | Drosophila melanogaster | - |
- |
- |
3.2.1.114 | Drosophila melanogaster | Q24451 | isoform GMII | - |
3.2.1.114 | Homo sapiens | - |
- |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
3.2.1.114 | - |
Drosophila melanogaster |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.2.1.24 | HCE cell | - |
Homo sapiens | - |
3.2.1.24 | LN-18 cell | - |
Homo sapiens | - |
3.2.1.24 | LNZ-308 cell | - |
Homo sapiens | - |
3.2.1.114 | endothelial cell line | HCEC | Homo sapiens | - |
3.2.1.114 | glioblastoma cell line | LNZ 308 | Homo sapiens | - |
3.2.1.114 | LN-18 cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.2.1.24 | 4-methylumbelliferyl-alpha-D-mannopyranoside + H2O | - |
Homo sapiens | 4-methylumbelliferone + D-mannose | - |
? | |
3.2.1.114 | 4-methyl-umbelliferyl-alpha-D-mannopyranoside + H2O | 30 min, 37°C | Homo sapiens | 4-methyl-umbelliferone + alpha-D-mannopyranose | - |
? | |
3.2.1.114 | 4-methylumbelliferyl alpha-D-mannoside + H2O | - |
Homo sapiens | 4-methylumbelliferone + alpha-D-mannose | - |
? | |
3.2.1.114 | 4-nitrophenyl-alpha-D-mannopyranoside + H2O | 30 min, 37°C | Canavalia ensiformis | 4-nitrophenol + alpha-D-mannopyranose | - |
? | |
3.2.1.114 | 4-nitrophenyl-alpha-D-mannopyranoside + H2O | 30 min, 20°C | Drosophila melanogaster | 4-nitrophenol + alpha-D-mannose | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.2.1.114 | alpha-mannosidase II | - |
Drosophila melanogaster |
3.2.1.114 | alpha-mannosidase II | - |
Homo sapiens |
3.2.1.114 | alpha-mannosidase II | - |
Canavalia ensiformis |
3.2.1.114 | dGMII | - |
Drosophila melanogaster |
3.2.1.114 | human type II alpha-mannosidase | - |
Homo sapiens |
3.2.1.114 | jack bean alpha-mannosidase | - |
Canavalia ensiformis |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.2.1.114 | 20 | - |
- |
Drosophila melanogaster |
3.2.1.114 | 37 | - |
- |
Homo sapiens |
3.2.1.114 | 37 | - |
- |
Canavalia ensiformis |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.2.1.24 | 0.000135 | - |
(2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | 37°C, pH 5.5 | Canavalia sp. | |
3.2.1.24 | 0.000155 | - |
(1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol | 37°C, pH 5.5 | Canavalia sp. | |
3.2.1.24 | 0.000206 | - |
(3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | 37°C, pH 5.5 | Canavalia sp. | |
3.2.1.24 | 0.004 | - |
(3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | 37°C, pH 5.5 | Canavalia sp. | |
3.2.1.114 | 0.00002 | - |
swainsonine | - |
Drosophila melanogaster | |
3.2.1.114 | 0.00002 | - |
(1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol | 20C, pH 6.8 | Drosophila melanogaster | |
3.2.1.114 | 0.000135 | - |
(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | - |
Canavalia ensiformis | |
3.2.1.114 | 0.000155 | - |
swainsonine | - |
Canavalia ensiformis | |
3.2.1.114 | 0.000206 | - |
(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | - |
Canavalia ensiformis | |
3.2.1.114 | 0.00055 | - |
(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | extracted from human glioblastoma cells LNZ308 | Homo sapiens | |
3.2.1.114 | 0.00067 | - |
(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | extracted from endothelial cells HCEC | Homo sapiens | |
3.2.1.114 | 0.001 | - |
(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | - |
Drosophila melanogaster | |
3.2.1.114 | 0.001 | - |
(3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | 20C, pH 6.8 | Drosophila melanogaster | |
3.2.1.114 | 0.0032 | - |
(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | extracted from human glioblastoma cells LN18 | Homo sapiens | |
3.2.1.114 | 0.004 | - |
(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | - |
Canavalia ensiformis | |
3.2.1.114 | 0.022 | - |
(3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | - |
Drosophila melanogaster | |
3.2.1.114 | 0.022 | - |
(3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | 20C, pH 6.8 | Drosophila melanogaster | |
3.2.1.114 | 0.0233 | - |
(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | extracted from endothelial cells HCEC | Homo sapiens | |
3.2.1.114 | 0.0325 | - |
(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | extracted from human glioblastoma cells LN18 | Homo sapiens | |
3.2.1.114 | 0.0415 | - |
(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | extracted from human glioblastoma cells LNZ308 | Homo sapiens | |
3.2.1.114 | 0.067 | - |
(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | - |
Drosophila melanogaster | |
3.2.1.114 | 0.067 | - |
(2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | 20C, pH 6.8 | Drosophila melanogaster |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
3.2.1.24 | 0.00001 | - |
pH 5.0, 37°C, HCEC cell layer | Homo sapiens | (1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol | |
3.2.1.24 | 0.00002 | - |
pH 5.0, 37°C, LNZ-308 cell layer | Homo sapiens | (1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol | |
3.2.1.24 | 0.00005 | - |
pH 5.0, 37°C, LN-18 cell layer | Homo sapiens | (1S,2R,8R,8aR)-octahydroindolizine-1,2,8-triol | |
3.2.1.24 | 0.0005 | - |
pH 5.0, 37°C, HCEC cell layer | Homo sapiens | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | |
3.2.1.24 | 0.0005 | - |
pH 5.0, 37°C, LNZ-308 cell layer | Homo sapiens | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | |
3.2.1.24 | 0.002 | - |
pH 5.0, 37°C, LN-18 cell layer | Homo sapiens | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | |
3.2.1.24 | 0.025 | - |
pH 5.0, 37°C, HCEC cell layer | Homo sapiens | (2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | |
3.2.1.24 | 0.05 | - |
pH 5.0, 37°C, LN-18 cell layer | Homo sapiens | (2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | |
3.2.1.24 | 0.05 | - |
pH 5.0, 37°C, LNZ-308 cell layer | Homo sapiens | (2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | |
3.2.1.24 | 0.05 | - |
pH 5.0, 37°C, LNZ-308 cell layer | Homo sapiens | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | |
3.2.1.24 | 0.075 | - |
pH 5.0, 37°C, HCEC cell layer | Homo sapiens | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | |
3.2.1.24 | 0.35 | - |
pH 5.0, 37°C, LN-18 cell layer | Homo sapiens | (3R,4R,5R)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | |
3.2.1.114 | 0.00001 | - |
extracted from endothelial cells HCEC | Homo sapiens | swainsonine | |
3.2.1.114 | 0.00002 | - |
extracted from human glioblastoma cells LNZ308 | Homo sapiens | swainsonine | |
3.2.1.114 | 0.00005 | - |
extracted from human glioblastoma cells LN18 | Homo sapiens | swainsonine | |
3.2.1.114 | 0.0005 | - |
extracted from endothelial cells HCEC | Homo sapiens | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | |
3.2.1.114 | 0.0005 | - |
extracted from human glioblastoma cells LNZ308 | Homo sapiens | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | |
3.2.1.114 | 0.00075 | - |
extracted from endothelial cells HCEC | Homo sapiens | (3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxy-1-methylpyrrolidin-2-one | |
3.2.1.114 | 0.002 | - |
extracted from human glioblastoma cells LN18 | Homo sapiens | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-1-methylpyrrolidin-2-one | |
3.2.1.114 | 0.0075 | - |
extracted from human glioblastoma cells LNZ308 | Homo sapiens | (3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxy-1-methylpyrrolidin-2-one | |
3.2.1.114 | 0.025 | - |
extracted from endothelial cells HCEC | Homo sapiens | (2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | |
3.2.1.114 | 0.05 | - |
extracted from human glioblastoma cells LN18 | Homo sapiens | (2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | |
3.2.1.114 | 0.05 | - |
extracted from human glioblastoma cells LNZ308 | Homo sapiens | (2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol | |
3.2.1.114 | 0.05 | - |
extracted from human glioblastoma cells LNZ308 | Homo sapiens | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | |
3.2.1.114 | 0.075 | - |
extracted from endothelial cells HCEC | Homo sapiens | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | |
3.2.1.114 | 0.075 | - |
extracted from endothelial cells HCEC | Homo sapiens | (2S,3R,4S)-2-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]pyrrolidine-3,4-diol | |
3.2.1.114 | 0.075 | - |
extracted from endothelial cells HCEC | Homo sapiens | (3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxypyrrolidin-2-one | |
3.2.1.114 | 0.075 | - |
extracted from human glioblastoma cells LN18 | Homo sapiens | (3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxy-1-methylpyrrolidin-2-one | |
3.2.1.114 | 0.075 | - |
extracted from human glioblastoma cells LNZ308 | Homo sapiens | (2S,3R,4S)-2-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]pyrrolidine-3,4-diol | |
3.2.1.114 | 0.15 | - |
extracted from human glioblastoma cells LNZ308 | Homo sapiens | (3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxypyrrolidin-2-one | |
3.2.1.114 | 0.2 | - |
extracted from human glioblastoma cells LN18 | Homo sapiens | (2S,3R,4S)-2-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]pyrrolidine-3,4-diol | |
3.2.1.114 | 0.35 | - |
extracted from human glioblastoma cells LN18 | Homo sapiens | (3R,4R,5S)-3,4-dihydroxy-5-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidin-2-one | |
3.2.1.114 | 0.75 | - |
extracted from human glioblastoma cells LN18 | Homo sapiens | (3R,4R,5S)-5-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]-3,4-dihydroxypyrrolidin-2-one |